Rentokil Initial/£RTO

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Rentokil Initial

Rentokil Initial plc, ticker RTO, is a United Kingdom-based company specializing in pest control, hygiene, and wellbeing services. The company operates globally with a presence in regions including North America, Europe, the UK, Asia, and the Pacific. Founded in 1925, Rentokil Initial has grown to become a leader in providing services that ensure environments are clean, safe, and healthy.

Ticker

£RTO

Sector

Business services

Primary listing

LSE

Employees

68,485

Rentokil Initial Metrics

BasicAdvanced
£9.3B
38.12
£0.10
0.33
£0.09
2.44%

What the Analysts think about Rentokil Initial

Analyst ratings (Buy, Hold, Sell) for Rentokil Initial stock.

Bulls say / Bears say

Selling the France workwear business to H.I.G. Capital for an enterprise value of €410 million (net proceeds about €370 million) will streamline the company around core pest control and hygiene offerings, and enhance the balance sheet.
Free cash flow for H1 2025 climbed 31% to $282 million with a 93% conversion rate versus 80% guidance, driven by better working capital and disciplined capex—supporting debt reduction and potential M&A.
Organic growth momentum in North America has improved: Q2 organic growth rose to 1.4% from 0.7% in Q1, and residential and termite leads increased 6.6% in June, signaling a possible early U.S. turnaround.
H1 2025 adjusted operating profit dropped 4.5% to $511 million and the adjusted operating margin shrank by 120 basis points to 15.2%, reflecting continued margin pressure.
The $6.7 billion Terminix acquisition continues to weigh on North American results, with Q1 U.S. sales rising just 0.5% and integration delays proving expensive and holding back growth.
Net debt rose to $4.22 billion (2.8× adjusted EBITDA) at end-H1 2025, limiting strategic options and highlighting dependence on debt financing.
Data summarised monthly by Lightyear AI. Last updated on 2 Sept 2025.

Rentokil Initial Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Rentokil Initial Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £RTO

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Sept22
Rentokil Initial
DividendPayment
$0.0415Per share
FAQs